Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI assistant aims to cut diagnostic errors in older adults

NCT ID NCT07553559

Diagnosis Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a new AI tool called INTERLACE that helps doctors diagnose older adults during primary care visits. The AI uses a patient's medical history, vital signs, and symptoms to suggest possible diagnoses and tests. Researchers want to see if the tool is easy to use and helpful for patients, caregivers, and doctors. The study involves 40 participants and focuses on whether the tool can be smoothly added to a regular doctor visit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence-based clinical decision support tool (INTERLACE)
What this could lead to
If successful, this could lead to a practical AI tool that helps doctors make faster and more accurate diagnoses for older adults, reducing harmful errors.
What could go wrong
This is a very early feasibility study with only 40 participants. The AI may not work well in real-world settings or could cause confusion. It is not yet proven to improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Clinicians 1. Work in the University of Pennsylvania Health System 2. Work in a primary care setting (i.e., Internal Medicine, Geriatric Medicine, Family Medicine, and Penn Primary Care) 3. Actively treat adult patients who are 65 years old or older Patients 1. 65 years of age or older 2. Have an upcoming encounter with a participating primary care clinician 3. Indicate a new or worsening health concern that they wish to discuss at the upcoming encounter Caregivers 1. 18 years old or older 2. Accompanying the participating patient during the encounter with the AI CDSS 3. Identified by the patient as a caregiver Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Under the age of 18 years old 2. Unable to provide informed consent in the opinion of the investigator 3. Has a "Research Do Not Contact" status in the electronic health record

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diagnostic support are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diagnostic support

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Pennsylvania

    Philadephia, Pennsylvania, 19104, United States